Is mean heart rate a reliable predictor in the pharmacotherapy of patients with atrial firbrillation?

Folia Cardiologica

Volumn 13, Issue 6, 2006, Pages 473-479

  Chudzik, Michał ^a   Wranicz, Jerzy Krzysztof ^a   Cygankiewicz, Iwona ^a   Klimczak, Artur ^a   Goch, Jan Henryk ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Atrial fibrillation; Heart rate irregularity; Ventricular rate control

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HEART RATE; HEART RHYTHM; HOLTER MONITORING; HUMAN; HYPERTENSION; MALE; SYMPTOM; TACHYCARDIA; VALVULAR HEART DISEASE;

EID: 33750342062     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kannel WB, Wolf PA, Benjamin EJ et al. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol, 1998; 82 (1 Suppl): N2-N9.
2. Epstein AE. Strategies for rate control. In: Kowey P., Naccarelli GV ed. Atrial fibrillation. Marcel Dekker & Company, New York 2005; 121-134
3. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789-1794.
4. Carlsson J. Mortality and stroke rates in trial of rhythm control versus rate control in atrial fibrillation: results from the STAF pilot phase (Strategies of Treatment of Atrial Fibrillation). Am Coll Cardiol 2001; 38: 603.
5. Galder IC, Hagens VE, Bosker HA et al. For the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med, 2002; 347: 1834-1840.
6. The Atrial Fibrillation Follow up Investigation of Rhythm Management (AFFIRM) investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002; 347: 1825-1833.
7. Opolski G, Torbicki A, Kosior DA et al. Rate control vs. rhythm control in patients with nonvalvular persistent atrial fibrilation: the results of the Polish How to Treat Chronic Atrial Fibrillation Study (HOT CAFE). Chest, 2004; 126: 476-486.
8. Fuster V, Ryden LE, Asinger RW et al. ACC/AHA//ESC guidelines for management of patients with atrial fibrillation. Circulation, 2001; 104: 2118-2150.
9. Wood MA. Ventricular rate control as an endpoint for the treatment of atrial fibrillation. Heart Rhythm, 2004; 1: B45-B51.
10. Naccarelli GV. An update on atrial fibrillation: a report from the Annual American Heart Association Session, New Orleans, 12-15.11.2000.
11. American College of Cardiology/American Heart Association, Task Force on Practice Guidelines and the European Society of Cardiology, Committee for Practice Guidelines and Policy Conferences: ACC/AHA//ESC guidelines for the management of patients with atrial fibrillation: Executive summary. Am J Coll Cardiol, 2001; 38: 1231-1265.
12. Schumacher B. Luderitz B. Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control. Am J Cardiol, 1998; 82 (8 Suppl A): 29N-36N.
13. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol, 1998; 21: 641-651.
14. ACC/AHA guidelines for ambulatory electrocardiography: Executive summary and recommendations. Circulation, 1999; 100: 886-947.
15. Greenhut SE, Fraser J, Steinhaus B, Feld G, Hughes W. Optimized standby rate reduces the ventricular rate variability in pacemaker patients with atrial fibrillation. Pacing Clin Electrophysiol, 1996; 19: 1780-1785.
16. Grogan M, Smith HC, Gersh BJ et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol, 1992; 69: 1570-1573.
17. Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R. Tachycardia- induced cardiomyopathy: A review of literature. Pacing Clin Electrophysiol, 2005; 28: 710-721.
18. Gassage AM, Braxton Hicks JA. On auricular fibrillation. QJM, 1913; 6: 435-440.
19. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med, 1988; 85: 242-244.
20. Grogan M, Smith HC, Gersh BJ et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol, 1992; 69: 1570-1573.
21. Rodriguez LM, Smeets JL, Xie B et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol, 1993; 72: 1137-1141.
22. Edner M, Caidahl K, Bergfeldt L et al. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J, 1995; 74: 261-267.
23. Byrne MJ, Raman JS, Alferness CA, Esler MD, Kaye DM, Power JM. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail, 2002; 8: 108-115.
24. Tomita M, Ikeguchi S, Kagawa K et al. Serial histopathologic myocardial findings in patients with ectopic atrial tachycardia-induced cardiomyopathy. J Cardiol, 1997; 29: 37-42.
25. Spinale FG, Holzgrefe HH, Mukherjee R, Arthur SR, Child MJ, Powell JR. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol, 1995; 268 (2 Pt 2): H836-H847.
26. Chudzik M, Wranicz JK, Cygankiewicz I, Goch JH, Kargul W. Pacemaker memory data compared to twenty four hour Holter monitoring in patients with VVI pacemaker and chronic atrial fibrillation. ANE, 2005; 10: 348-355.
27. Clark DM, Plumb VJ, Kay GN. The hemodynamics of atrial fibrillation: the independent effect of an irregular RR interval. Circulation, 1995; 92: I-141 (abstract).
28. Clark DM, Plumb VJ, Kay GN et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol, 1997; 30: 1039-1045.
29. Naito M, David D, Michelson EL. The hemodynamic consequence of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J, 1983; 106: 284-291.
30. Ueshima K, Myers J, Ribis PM et al. Exercise capacity and prognosis in patients with chronic atrial fibrillation. Cardiology, 1995; 86: 108-113.
31. Daoud EG, Weiss R, Bahu M. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol, 1996; 78: 1433-1436.
32. Natale A, Zimerman L, Tomassoni G. Impact on ventricular function and quality of life of transcatheter ablation of atrioventricular junction in chronic fibrillation with a normal ventricular response. Am J Cardiol, 1996; 78: 1431-1433.
33. Van Gelder IC, Crijns GM, Blanksma PK. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol, 1993; 72: 560-566.
34. Ueng KC, Tsai TP, Tsai CF et al. Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response. J Cardiovasc Electrophysiol, 2001; 12: 303-309.
35. Giani P, Giudici V, Leoni G. Heamodynamics of a regular and an irregular rhythm in atrial fibrillation. In: Santini M. ed. Progress in clinical pacing. 1998; Futura Media Services, Inc Armonk, NY 1998; 51-56.
36. Ellenbogen KA, Thames MD, Mohanty PK. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventricular pacing. Am J Cardiol, 1990; 65: 53-59.
37. Herbert WH. Cardiac output and the varying RR interval of atrial fibrillation. J Electrocardiol, 1973; 6: 131-135.
38. Lau CP, Jiang ZY, Tang MO. Efficacy of ventricular rate stabilization by right ventricular pacing during atrial fibrillation. Pacing Clin Electrophysiol, 1998; 21: 542-548.
39. Hamer ME, Blumenthal JA, McCarthy EA, Phillips BG, Pritchett ELC. Quality of life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. Am J Cardiol, 1994; 74: 826-829.
40. Jung W, Luderitz B. Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol, 1998; 9 (Suppl): 177-186.
41. Chudzik M, Wranicz JK, Goch JH, Kargul W. Wpływ stałej elektrostymulacji serca na stabilizacje rytmu u pacjentów z utrwalonym migotaniem przedsionków. Folia Cardiol. 2004; 11: 169-176.